These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 6545495

  • 1. Complement activation in renal disease.
    West CD.
    Uremia Invest; ; 8(3-4):225-35. PubMed ID: 6545495
    [Abstract] [Full Text] [Related]

  • 2. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH, Lambert PH, Miescher PA.
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [Abstract] [Full Text] [Related]

  • 3. Different Aspects of Classical Pathway Overactivation in Patients With C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis.
    Michels MAHM, van de Kar NCAJ, van Kraaij SAW, Sarlea SA, Gracchi V, Engels FAPT, Dorresteijn EM, van der Deure J, Duineveld C, Wetzels JFM, van den Heuvel LPWJ, Volokhina EB.
    Front Immunol; 2021 Jul; 12():715704. PubMed ID: 34456924
    [Abstract] [Full Text] [Related]

  • 4. A study of complement components C3, C5, C6, C7, C8 and C9 in chronic membranoproliferative glomerulonephritis, systemic lupus erythematosus, poststreptococcal nephritis, idiopathic nephrotic syndrome and anaphylactoid purpura.
    Geiger H, Good RA, Day NK.
    Z Kinderheilkd; 1975 Jul; 119(4):269-78. PubMed ID: 49134
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis.
    Blom AM, Corvillo F, Magda M, Stasiłojć G, Nozal P, Pérez-Valdivia MÁ, Cabello-Chaves V, Rodríguez de Córdoba S, López-Trascasa M, Okrój M.
    J Clin Immunol; 2016 Jul; 36(5):517-27. PubMed ID: 27146825
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Circulating immune complexes in membranoproliferative glomerulonephritis.
    Davis CA, Marder H, West CD.
    Kidney Int; 1981 Dec; 20(6):728-32. PubMed ID: 6801370
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus transformed B cell lines derived from patients with systemic lupus erythematosus produce a nephritic factor of the classical complement pathway.
    Hiramatsu M, Tsokos GC.
    Clin Immunol Immunopathol; 1988 Jan; 46(1):91-9. PubMed ID: 2826058
    [Abstract] [Full Text] [Related]

  • 14. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E, Yagüe J, Vives J, Revert L.
    Med Clin (Barc); 1981 Jun 10; 77(1):21-6. PubMed ID: 7253758
    [Abstract] [Full Text] [Related]

  • 15. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT, Daha MR, Strom TB, Weiler JM, Carpenter CB, Austen KF.
    Transplant Proc; 1977 Mar 10; 9(1):729-39. PubMed ID: 325806
    [Abstract] [Full Text] [Related]

  • 16. Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
    Daha MR, Van Es LA.
    Neth J Med; 1982 Mar 10; 25(7):202-7. PubMed ID: 6924073
    [No Abstract] [Full Text] [Related]

  • 17. Serum immune complexes in membranoproliferative and other glomerulonephritides.
    Ooi YM, Vallota EH, West CD.
    Kidney Int; 1977 Apr 10; 11(4):275-83. PubMed ID: 853604
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme.
    Halbwachs L, Leveillé M, Lesavre P, Wattel S, Leibowitch J.
    J Clin Invest; 1980 Jun 10; 65(6):1249-56. PubMed ID: 6902727
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.